Réactualisation de la méthode française d’imputabilité des effets indésirables des médicaments
Therapie, 66 6 (2011) 517-525
Publié en ligne : 2011-12-21
Article cité par
La fonctionnalité Article cité par… liste les citations d'un article. Ces citations proviennent de la base de données des articles de EDP Sciences, ainsi que des bases de données d'autres éditeurs participant au programme CrossRef Cited-by Linking Program. Vous pouvez définir une alerte courriel pour être prévenu de la parution d'un nouvel article citant " cet article (voir sur la page du résumé de l'article le menu à droite).
Article cité :
Citations de cet article :
From pharmacovigilance to pharmaceutical care: About a case of urticaria and angioedema
S. Mansour, FZN. Mekaouche, A. Amrani, FZ. Charif, F. Haouatti, H. Betaouaf, I. Senhadji, N. Bouchiba and H. ToumiRevue Française d'Allergologie 63 (7) 103712 (2023)
https://doi.org/10.1016/j.reval.2023.103712
Trends in adverse drug reactions related to oral weak opioid analgesics in therapeutic use in adults: A 10‐year French vigilances retrospective study
Weniko Caré, Sylvine Pinel, Laurène Dufayet, Jérôme Langrand, Joëlle Micallef and Dominique VodovarFundamental & Clinical Pharmacology 37 (6) 1205 (2023)
https://doi.org/10.1111/fcp.12929
Utilisation du dronabinol dans le traitement des douleurs neuropathiques réfractaires : retour d’expérience des patients suivis dans un Centre d’évaluation et de traitement de la douleur
E. Richet, L. Ferret, L. Gaboriau, P. Charpentier, L. Dujardin, J. Fulcrand and A. BoursierAnnales Pharmaceutiques Françaises 81 (4) 720 (2023)
https://doi.org/10.1016/j.pharma.2022.12.005
Reality of drug-induced erythema multiforme: A French pharmacovigilance study
Sarah Demouche, Thomas Bettuzzi, Emilie Sbidian, Delphine Laugier Castellan, Marie-Noelle Osmont, Saskia Ingen-Housz-Oro and Bénédicte Lebrun-VignesTherapies 78 (6) 711 (2023)
https://doi.org/10.1016/j.therap.2023.03.004
Adverse cutaneous reactions to psychotropic drugs
A. El Kissouni, F. Hali, S. Chiheb, A. Meftah and H. FilaliRevue Française d'Allergologie 63 (5) 103668 (2023)
https://doi.org/10.1016/j.reval.2023.103668
Évaluation de l’imputabilité médicamenteuse devant une suspicion de toxidermie
G. Gourier, S. Ingen-Housz-Oro, P. Sanchez-Pena and B. Lebrun-VignesAnnales de Dermatologie et de Vénéréologie - FMC 3 (6) 399 (2023)
https://doi.org/10.1016/j.fander.2023.02.011
Revue de la littérature sur la pharmacovigilance des médicaments issus des pharmacopées traditionnelles. Partie II : évaluation et prévention des risques
K. Ouoba, H. Lehmann, J.-Y. Pabst and R. SemdeAnnales Pharmaceutiques Françaises 80 (5) 635 (2022)
https://doi.org/10.1016/j.pharma.2021.11.007
Amiodarone induced lung disease
Cristina Elena Mitrofan, Aurelia Cretu and Costel MitrofanArchive of Clinical Cases 9 (3) 126 (2022)
https://doi.org/10.22551/2022.36.0903.10217
Baclofen-induced psoriasis
N. Sigg, J. Delaunay, C. Potey and G. DrablierAnnales de Dermatologie et de Vénéréologie 149 (4) 291 (2022)
https://doi.org/10.1016/j.annder.2022.03.009
Pulmonary hemorrhage in a neonate born to a woman with cystic fibrosis treated with targeted cystic fibrosis transmembrane conductance regulator modulator elexacaftor–tezacaftor–ivacaftor during pregnancy
Alexandra Nuytten, Anne Prevotat, Olivier Le Rouzic, Joëlle Dekemp, Sixtine Gilliot, Sophie Gautier, Kévin Le Duc and Charles GarabedianTherapies 77 (6) 743 (2022)
https://doi.org/10.1016/j.therap.2022.01.020
Reversible anti-TNFα treatment induced dementia: A case report
Camille Hou, Emmanuel Azzi, Anne Salmon, Marie-Noëlle Osmont and Aleth PerdrigerJoint Bone Spine 88 (1) 105044 (2021)
https://doi.org/10.1016/j.jbspin.2020.06.017
Impact of a medico-pharmaceutical follow-up and an optimized communication between hospital and community on the readmission to the emergency department for an adverse drug event: URGEIM, study protocol for a randomized controlled trial
Cyril Breuker, Marie Faucanié, Marion Laureau, Damien Perier, Véronique Pinzani, Grégory Marin, Mustapha Sebbane and M. VillietTrials 22 (1) (2021)
https://doi.org/10.1186/s13063-021-05501-4
Childhood epidermal necrolysis and erythema multiforme major: a multicentre French cohort study of 62 patients
L. Giraud‐Kerleroux, N. Bellon, A. Welfringer‐Morin, S. Leclerc‐Mercier, I. Costedoat, J. Coquin, A. Brun, A.‐M. Roguedas‐Contios, C. Bernier, B. Milpied, F. Tétart, A. Du Thanh, N. Cordel, B. Bensaid, C. Fargeas, M. Tauber, S. Renolleau, F. Boralevi, S. Ingen‐Housz‐Oro and C. BodemerJournal of the European Academy of Dermatology and Venereology 35 (10) 2051 (2021)
https://doi.org/10.1111/jdv.17469
Hospital databases for the identification of adverse drug reactions: A 2‐year multicentre study in 9 French general hospitals
Marie‐Noëlle Osmont, Adeline Degremont, Hélène Jantzem, Youna Audouard‐Marzin, Sébastien Lalanne, Dominique Carlhant‐Kowalski, Eric Bellissant, Emmanuel Oger and Elisabeth PolardBritish Journal of Clinical Pharmacology 87 (2) 471 (2021)
https://doi.org/10.1111/bcp.14405
Hemangiol in infantile haemangioma: A paediatric post‐marketing surveillance drug study
Floriane Socchi, Michele Bigorre, Marion Normandin, Guillaume Captier, Didier Bessis, Michel Mondain, Catherine Blanchet, Mohamed Akkari, Pascal Amedro and Arthur GavottoBritish Journal of Clinical Pharmacology 87 (4) 1970 (2021)
https://doi.org/10.1111/bcp.14593
Interaction tamoxifène – clou de girofle : à propos d’un cas d’effet indésirable
S. Abou, J.-M. Ouedraogo, B. Hafsa, M.J. Belahcen and Y. RahaliLe Pharmacien Hospitalier et Clinicien 56 (2) 185 (2021)
https://doi.org/10.1016/j.phclin.2020.11.005
Allopurinol-Induced Oral Lichenoid Drug Reaction with Complete Regression after Drug Withdrawal
Alexandre Perez, Benjamin Lazzarotto, Jean-Pierre Carrel and Tommaso LombardiDermatopathology 7 (1) 18 (2020)
https://doi.org/10.3390/dermatopathology7010004
Démence réversible à l’arrêt d’un traitement par anti-TNFα
Camille Hou, Emmanuel Azzi, Anne Salmon, Marie-Noëlle Osmont and Aleth PerdrigerRevue du Rhumatisme 87 (6) 486 (2020)
https://doi.org/10.1016/j.rhum.2020.09.012
Severe Attack of Henoch-Schönlein Purpura With Neurological Involvement During Adalimumab Treatment for Crohn’s Disease
Manuelle Viguier, Guillaume Cadiot, Jean-Hugues Salmon, et al.Journal of Crohn's and Colitis 14 (4) 538 (2020)
https://doi.org/10.1093/ecco-jcc/jjz164
Transient major hypothermia associated with acetaminophen: A pediatric case report and literature review
M.-S. Agier, N. Chollet, E. Bediou, M. Boyer Gervoise and A.-P. Jonville-BeraArchives de Pédiatrie 26 (6) 358 (2019)
https://doi.org/10.1016/j.arcped.2019.06.005
Vascularites médicamenteuses : à propos d’une série de 13 cas
Neila Fathallah, Bouraoui Ouni, Sana Mokni, et al.Therapies 74 (3) 347 (2019)
https://doi.org/10.1016/j.therap.2018.07.005
Adverse reactions related to brentuximab vedotin use: A real-life retrospective study
Béatrice Clarivet, Laure Vincent, Laurence Vergely, et al.Therapies 74 (3) 343 (2019)
https://doi.org/10.1016/j.therap.2018.07.004
Comparative study of hypoglycaemia induced by opioids. Is it a class effect?
Basile Chrétien, Charles Dolladille, Léa Hamel-Sénécal, et al.Expert Opinion on Drug Safety 18 (10) 987 (2019)
https://doi.org/10.1080/14740338.2019.1646246
Gliptin Accountability in Mucous Membrane Pemphigoid Induction in 24 Out of 313 Patients
Olivier Gaudin, Vannina Seta, Marina Alexandre, et al.Frontiers in Immunology 9 (2018)
https://doi.org/10.3389/fimmu.2018.01030
Étude de la néphrotoxicité induite par les plantes chez les patients du service de néphrologie
N. Touiti, I. Iken, M. Chebaibi, S. Achour and T. Sqalli HoussainiToxicologie Analytique et Clinique 30 (2) S63 (2018)
https://doi.org/10.1016/j.toxac.2018.04.084
Toxicodynetics in nordiazepam and oxazepam overdoses
L. Sacre, S.M. Ali, A. Villa, et al.Annales Pharmaceutiques Françaises 75 (3) 163 (2017)
https://doi.org/10.1016/j.pharma.2017.01.002
A case report of rare palmoplantar keratosis and nail dystrophy with imatinib
M. Benabbes, Z. Tazi Mezalek and B. MeddahAnnales Pharmaceutiques Françaises 75 (3) 172 (2017)
https://doi.org/10.1016/j.pharma.2016.12.006
Syndrome de Lyell aux anti-PD1 d’évolution fatale
S. Demirtas, L. El Aridi, M. Acquitter, C. Fleuret and P. PlantinAnnales de Dermatologie et de Vénéréologie 144 (1) 65 (2017)
https://doi.org/10.1016/j.annder.2016.11.012
Causality assessment in pharmacovigilance: The French method and its successive updates
Ghada Miremont-Salamé, Hélène Théophile, Françoise Haramburu and Bernard BégaudTherapies 71 (2) 179 (2016)
https://doi.org/10.1016/j.therap.2016.02.010
Toxicodynetics: A new discipline in clinical toxicology
F.J. Baud, P. Houzé, A. Villa, S.W. Borron and P. CarliAnnales Pharmaceutiques Françaises 74 (3) 173 (2016)
https://doi.org/10.1016/j.pharma.2016.02.003
Imputabilité en pharmacovigilance : de la méthode française originelle aux méthodes réactualisées
Ghada Miremont-Salamé, Hélène Théophile, Françoise Haramburu and Bernard BégaudTherapies 71 (2) 171 (2016)
https://doi.org/10.1016/j.therap.2016.02.009
High-Dose Verapamil in Episodic and Chronic Cluster Headaches and Cardiac Adverse Events: Is It as Safe as We Think?
Joachim Alexandre, Xavier Humbert, Marion Sassier, et al.Drug Safety - Case Reports 2 (1) (2015)
https://doi.org/10.1007/s40800-015-0015-3
Chocs anaphylactiques peranesthésiques : contribution d'un entrepôt de données cliniques
Marie-Noëlle Osmont, Boris Campillo-Gimenez, Lucie Metayer, et al.Thérapie (2015)
https://doi.org/10.2515/therapie/2015055
Iatrogénie médicamenteuse : contribution à l’uniformisation de la terminologie en langue française pour la pratique de soins et la recherche clinique
Lucien Roulet, Françoise Ballereau, Maryse Lapeyre-Mestre, Muriel Joris-Frasseren and Nathalie AsserayThérapie 70 (3) 283 (2015)
https://doi.org/10.2515/therapie/2014215
Adverse Drug Reactions in Pediatric Emergency Medicine
Domitille Darnis, Julien Mahé, Bénédicte Vrignaud, et al.Annals of Pharmacotherapy 49 (12) 1298 (2015)
https://doi.org/10.1177/1060028015602904
Cardiac Arrests Associated with Low Plasma and Tissue Levels of Local Anaesthetics
Joachim Alexandre, Xavier Humbert, Marion Sassier, et al.Thérapie (2015)
https://doi.org/10.2515/therapie/2015056
Linear immunoglobulin A disease and vancomycin: letter in reply
S. Ingen-Housz-Oro, L. Valeyrie-Allanore, J. Chanal, O. Chosidow and P. WolkensteinBritish Journal of Dermatology 171 (6) 1602 (2014)
https://doi.org/10.1111/bjd.13174
Facial Hyperpigmentation during Imatinib Therapy for Gastrointestinal Stromal Tumor
Imene Hamza, Emna Gaies, Sarrah Kastalli, Riadh Daghfous and Sihem El AidliTherapies 69 (3) 245 (2014)
https://doi.org/10.2515/therapie/2014018
Risk Assessment of Dimethylfumarate Residues in Dwellings Following Contamination by Treated Furniture
C. Rousselle, V. Pernelet‐Joly, C. Mourton‐Gilles, J. P. Lepoittevin, R. Vincent, A. Lefranc and R. GarnierRisk Analysis 34 (5) 879 (2014)
https://doi.org/10.1111/risa.12147
Toxidermie pityriasis rosé de Gibert-like induite par la pristinamycine
Sana Mokni, Hichem Belhadjali, Jihane Alkhalifa, et al.Therapies 68 (5) 326 (2013)
https://doi.org/10.2515/therapie/2013046
Acute Hepatitis and Renal Failure Related to Intranasal Buprenorphine Misuse
Céline Eiden, Marie-Pierre Ripault, Dominique Larrey, et al.Annals of Pharmacotherapy 47 (12) 1721 (2013)
https://doi.org/10.1177/1060028013507429
Pneumopathies médicamenteuses en réanimation
J. Mankikian, A. -P. Jonville-Bera, P. Diot, et al.Réanimation 22 (1) 62 (2013)
https://doi.org/10.1007/s13546-012-0645-8
Linear IgA bullous dermatosis: comparison between the drug-induced and spontaneous forms
J. Chanal, S. Ingen-Housz-Oro, N. Ortonne, et al.British Journal of Dermatology 169 (5) 1041 (2013)
https://doi.org/10.1111/bjd.12488